Keyword Pages
psoriasis epidemiology screening tool 483
psoriasis 483
psoriatic arthritis 483
screening questionnaire. 483
ankle-brachial index 495
carotid intima-media thickness 495
heart disease risk factors 495
systemic lupus erythematosus 495, 527
vascular stiffness. 495
cytochrome c oxidase subunits 1 504
malondialdehyde 504
oxidative stress 504
systemic lupus erythematosus. 504, 566, 626
carpal tunnel syndrome 517
steroid phonophoresis 517
ultrasound. 517
disease activity 527, 593
lupus nephritis 527
urinary plasmin. 527
gouty arthritis 536
inflammation 536
mirna-23a-5p 536
myd88 536
nf-&kappa 536
b 536
tlr2. 536
clinical examination 547
juvenile idiopathic arthritis 547
magnetic resonance imaging 547
shoulder joint. 547
coronaphobia 559
physical activity 559
rheumatoid arthritis. 559
complement receptor 2 566
mutation 566
sequencing 566
cervical radiculopathy 574
disability evaluation 574
herniated disc 574
pain measurement 574
questionnaire. 574
dyslipidemia 584
gene polymorphism 584
low-density lipoprotein cholesterol 584
lupus 584
nephritis. 584
abnormal lipid level 593
insulin resistance 593
very early rheumatoid arthritis. 593
kinesiophobia 603
remission 603
rheumatoid arthritis 603, 613
pain 603
physical activity. 603
etanercept 613
genetic polymorphism 613
response 613
tumor necrosis factor-alpha. 613
anti-double-stranded deoxyribonucleic acid 626
antinuclear antibody 626
antiphospholipid antibody 626
complement 626